Covid-19 Drug Duo Achievements: GoldenBiotech’s New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries Read More » February 4, 2021
Covid-19 Drug Duo Achievements: GoldenBiotech’s New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review Read More » February 4, 2021
Breakthrough in AML Treatment: GoldenBiotech Reports New Drug Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed Acute Myeloid Leukemia Read More » November 26, 2020
Coronavirus Covid-19 Clinical Trial Agreement Signed – Partnering with Ascension Via Christi in USA Advancing GoldenBiotech’s New Drug Antroquinonol Read More » October 12, 2020
